Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA

Warren, Luigi, Manos, Philip D., Ahfeldt, Tim, Loh, Yuin-Han, Li, Hu, Lau, Frank, Ebina, Wataru, Mandal, Pankaj K. +8 more·2010·Cell Stem Cell

Cited by (1,006)

Items 201–300 of 1,006

  1. High-efficiency RNA-based reprogramming of human primary fibroblasts
    Igor Kogut, Sandra M. McCarthy, Maryna Pavlova, David P. Astling, Xiaomi Chen, Ana Jakimenko, Kenneth L. Jones, Andrew Getahun, John C. Cambier, Anna M.G. Pasmooij et al. · 2018 · Nature Communications
  2. The Role of Human Leukocyte Antigen Matching in the Development of Multiethnic “Haplobank” of Induced Pluripotent Stem Cell Lines
    Pierre‐Antoine Gourraud, Leena Gilson, Mathilde Girard, Marc Peschanski · 2011 · Stem Cells
  3. Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells
    Rekha Samuel, L. Daheron, S. Liao, Trupti D Vardam, W. Kamoun, Ana L. Batista, Christa Buecker, R. Schäfer, Xiaoxing Han, Patrick Au et al. · 2013 · Proceedings of the National Academy of Sciences of the United States of America
  4. Engineering bone tissue from human embryonic stem cells
    Darja Marolt, Iván Marcos-Campos, Sarindr Bhumiratana, Ana Koren, Petros D. Petridis, Geping Zhang, Patrice F. Spitalnik, Warren L. Grayson, Gordana Vunjak‐Novakovic · 2012 · Proceedings of the National Academy of Sciences
  5. Molecular Signatures of Human Induced Pluripotent Stem Cells Highlight Sex Differences and Cancer Genes
    Montserrat C. Anguera, Ruslan I. Sadreyev, Zhao-Qing Zhang, A. Szántó, Bernhard Payer, S. Sheridan, Show-ming Kwok, S. Haggarty, M. Sur, Jason Alvarez et al. · 2012 · Cell Stem Cell
  6. Stem Cell Therapy to Cure Type 1 Diabetes: From Hype to Hope
    P. Chhabra, K. Brayman · 2013 · Stem Cells Translational Medicine
  7. Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells
    Jonghyeob Lee, T. Sugiyama, Ying-Hua Liu, Jing Wang, Xue-Ying Gu, J. Lei, J. Markmann, Satsuki Miyazaki, J. Miyazaki, G. Szot et al. · 2013 · eLife
  8. Small molecules, big roles – the chemical manipulation of stem cell fate and somatic cell reprogramming
    Yu Zhang, Wenlin Li, Timothy Laurent, Sheng Ding · 2012 · Journal of Cell Science
  9. Constructing and Deconstructing Stem Cell Models of Neurological Disease
    Han, Steve S.W., Williams, Luis A., Eggan, Kevin C. · 2011 · Neuron
  10. Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across
    Minnaert, An-Katrien, Vanluchene, Helena, Verbeke, Rein, Lentacker, Ine, De Smedt, Stefaan C., Raemdonck, Koen, Sanders, Niek N., Remaut, Katrien · 2021 · Advanced Drug Delivery Reviews
  11. Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach
    Dafni Moschidou, Sayandip Mukherjee, Michael P. Blundell, Katharina Drews, Gemma N. Jones, Hassan Abdulrazzak, Beata Nowakowska, Anju G. S. Phoolchund, Kenneth Lay, Thamil Selvee Ramasamy et al. · 2012 · Molecular Therapy
  12. Feeder-Free Derivation of Human Induced Pluripotent Stem Cells with Messenger RNA
    Warren, Luigi, Ni, Yuhui, Wang, Jiwu, Guo, Xirong · 2012 · Scientific Reports
  13. Cell-Based Therapy for Degenerative Retinal Disease
    Marco A. Zarbin · 2016 · Trends in Molecular Medicine
  14. Quantification of nanowire penetration into living cells
    Alexander M. Xu, Amin Aalipour, Sergio Leal‐Ortiz, Armen H. Mekhdjian, Xi Xie, Alexander R. Dunn, Craig Curtis Garner, Nicholas A. Melosh · 2014 · Nature Communications
  15. microRNAs: important regulators of stem cells
    Na Li, Bo Long, Wei Han, Shumin Yuan, Kun Wang · 2017 · Stem Cell Research & Therapy
  16. Cell-based transplantation strategies to promote plasticity following spinal cord injury
    Crystal A. Ruff, Jared T. Wilcox, Michael George Fehlings · 2011 · Experimental Neurology
  17. Induced Pluripotent Stem Cells for Regenerative Medicine
    Karen K. Hirschi, Song Li, Krishnendu Roy · 2014 · Annual Review of Biomedical Engineering
  18. Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells
    Yongming Ren, Min Young Lee, Simon Schliffke, Jere Paavola, Peter J. Amos, Xin Ge, Mingyu Ye, Shenjun Zhu, Grant D. Senyei, Lawrence Lum et al. · 2011 · Journal of Molecular and Cellular Cardiology
  19. Synthetic mRNA Encoding VEGF-A in Patients Undergoing Coronary Artery Bypass Grafting: Design of a Phase 2a Clinical Trial
    Vesa Anttila, Antti Saraste, Juhani M. Knuuti, Pekka A. Jaakkola, Marja Hedman, Sara Svedlund, Maria Lagerstrom Fermer, Magnus Kjaer, Anders Jeppsson, Li‐Ming Gan · 2020 · Molecular Therapy — Methods & Clinical Development
  20. Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy
    Sara E. Howden, Athurva Gore, Zhe Li, Ho-Lim Fung, Benjamin S. Nisler, Jeff Nie, Goukai Chen, Brian E. McIntosh, Daniel R. Gulbranson, Nicole R. Diol et al. · 2011 · Proceedings of the National Academy of Sciences
  21. Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2
    Sangho Lee, Changwon Park, Ji Woong Han, Ju Young Kim, Kyu-Won Cho, Sangsung Kim, Sangsung Kim, Shin-Jeong Lee, Se Yeong Oh, Yoshiaki Tanaka et al. · 2016 · Circulation Research
  22. A Potent Branched-Tail Lipid Nanoparticle Enables Multiplexed mRNA Delivery and Gene Editing In Vivo
    Khalid A. Hajj, Jilian R. Melamed, Namit Chaudhary, Nicholas G. Lamson, Rebecca L. Ball, Saigopalakrishna S. Yerneni, Kathryn A. Whitehead · 2020 · Nano Letters
  23. Immunity to CRISPR Cas9 and Cas12a therapeutics
    Wei Leong Chew · 2017 · WIREs Systems Biology and Medicine
  24. Poking cells for efficient vector-free intracellular delivery
    Ying Wang, Yang Yang, Li Yan, So-Ying Kwok, Wei Li, Zhigang Wang, Xiaoyue Aelita Zhu, Guangyu Zhu, Wenjun Zhang, Xianfeng Chen et al. · 2014 · Nature Communications
  25. Biomimetic Platforms for Human Stem Cell Research
    Gordana Vunjak‐Novakovic, David T. Scadden · 2011 · Cell stem cell
  26. Regeneration of the heart
    Matthew L. Steinhauser, Richard Theodore Lee · 2011 · EMBO Molecular Medicine
  27. Pluripotent stem cell-based therapy for Parkinson’s disease: Current status and future prospects
    Kai‐Christian Sonntag, Bin Song, Nayeon Lee, Jin Hyuk Jung, Young Cha, Pierre R Leblanc, Carolyn Neff, Sek Won Kong, Bob S. Carter, Jeffrey Schweitzer et al. · 2018 · Progress in Neurobiology
  28. Non-viral delivery of the CRISPR/Cas system: DNA versus RNA versus RNP
    Yi Lin, Ernst Wagner, Ulrich Lächelt · 2022 · Biomaterials Science
  29. Concise Review: Workshop Review: Understanding and Assessing the Risks of Stem Cell-Based Therapies
    James A. Heslop, Thomas G. Hammond, Ilaria Santeramo, Agnès Tort Piella, Isabel Hopp, Jing Zhou, Roua S. Baty, Enrique I. Graziano, Bernabé Proto Marco, Alexis Caron et al. · 2015 · Stem Cells Translational Medicine
  30. Nanomedicine-Based Approaches for mRNA Delivery
    Uchida, Satoshi, Perche, Federico, Pichon, Chantal, Cabral, Horacio · 2020 · Molecular Pharmaceutics
  31. Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome
    Caroline Y. Kuo, Joseph D. Long, Beatriz Campo-Fernández, Satiro Nakamura De Oliveira, Aaron R. Cooper, Zulema G. Romero, Megan D. Hoban, Alok V. Joglekar, Georgia R. Lill, Michael L. Kaufman et al. · 2018 · Cell Reports
  32. Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives
    Helena D. Zomer, Atanásio Serafim Vidane, Natalia N Gonçalves, Carlos Eduardo Ambrósio · 2015 · Stem Cells and Cloning Advances and Applications
  33. Immunological Applications of Stem Cells in Type 1 Diabetes
    Paolo Fiorina, Júlio César Voltarelli, Nicholas Zavazava · 2011 · Endocrine Reviews
  34. Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming
    Xiao Zhang, F D Cruz, Mary Beth Terry, Fabrizio Remotti, Igor Matushansky · 2012 · Oncogene
  35. Concise Review: Genomic Stability of Human Induced Pluripotent Stem Cells
    Kristen Martins‐Taylor, Ren‐He Xu · 2011 · Stem Cells
  36. Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy
    Akram Al Abbar, Siew Ching Ngai, Nadine Nograles, Suleiman Yusuf Alhaji, Syahril Abdullah · 2020 · BioResearch open access
  37. Induced Pluripotent Stem Cells for Post–Myocardial Infarction Repair
    Pratik A Lalit, Derek J. Hei, Amish N. Raval, Timothy J. Kamp · 2014 · Circulation Research
  38. Regulation of innate immunity through RNA structure and the protein kinase PKR
    Subba Rao Nallagatla, Rebecca Toroney, Philip C. Bevilacqua · 2010 · Current Opinion in Structural Biology
  39. Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease
    Patricia Kim Phuong Nguyen, Evgenios A. Neofytou, June‐Wha Rhee, Joseph C. Wu · 2016 · JAMA Cardiology
  40. Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
    Jessica Foster, Namrata Choudhari, Jessica Perazzelli, Julie Storm, Ted J. Hofmann, Payal Jain, Phillip B. Storm, Norbert Pardi, Drew Weissman, Angela Jae Waanders et al. · 2018 · Human Gene Therapy
  41. Synthetic biology in the clinic: engineering vaccines, diagnostics, and therapeutics
    Xiao Tan, Justin H. Letendre, James J. Collins, Wilson W. Wong · 2021 · Cell
  42. Functional differentiation of human pluripotent stem cells on a chip
    Giovanni Giuseppe Giobbe, Federica Michielin, Camilla Luni, Stefano Giulitti, Sebastian Martewicz, Sirio Dupont, Annarosa Floreani, Nicola Elvassore · 2015 · Nature Methods
  43. Genome-wide RNA-Seq of Human Motor Neurons Implicates Selective ER Stress Activation in Spinal Muscular Atrophy
    Shi‐Yan Ng, Boon-Seng Soh, Natalia Rodríguez‐Muela, David G. Hendrickson, Feodor D. Price, John L. Rinn, Lee L. Rubin · 2015 · Cell stem cell
  44. In Vivo Messenger RNA Introduction into the Central Nervous System Using Polyplex Nanomicelle
    Satoshi Uchida, Keiji Itaka, Hirokuni Uchida, Kentaro Hayakawa, Toru Ogata, Takehiko Ishii, Shigeto Fukushima, Kensuke Osada, Kazunori Kataoka · 2013 · PLoS ONE
  45. Nanoplatforms for mRNA Therapeutics
    Meng, Chaoyang, Chen, Zhe, Li, Gang, Welte, Thomas, Shen, Haifa · 2021 · Advanced Therapeutics
  46. Bone tissue engineering via human induced pluripotent, umbilical cord and bone marrow mesenchymal stem cells in rat cranium
    Ping Wang, Xian Liu, Liang Zhao, Michael D. Weir, Jirun Sun, Wenchuan Chen, Yi Man, Hockin H.K. Xu · 2015 · Acta Biomaterialia
  47. Enhanced Lung Epithelial Specification of Human Induced Pluripotent Stem Cells on Decellularized Lung Matrix
    Sarah E. Gilpin, Xi Ren, Tatsuya Okamoto, Jacques P. Guyette, Hongmei Mou, Jayaraj Rajagopal, Douglas J. Mathisen, Joseph Phillip Vacanti, Harald C. Ott · 2014 · The Annals of Thoracic Surgery
  48. 7q11.23 dosage-dependent dysregulation in human pluripotent stem cells affects transcriptional programs in disease-relevant lineages
    Adamo, Antonio, Atashpaz, Sina, Germain, Pierre-Luc, Zanella, Matteo, D'Agostino, Giuseppe, Albertin, Veronica, Chenoweth, Josh, Micale, Lucia, Fusco, Carmela, Unger, Christian et al. · 2015 · Nature Genetics
  49. Neural stem cell therapy—Brief review
    Cezary Grochowski, Elżbieta Radzikowska, Ryszard Maciejewski · 2018 · Clinical Neurology and Neurosurgery
  50. Treatment of Parkinson’s Disease through Personalized Medicine and Induced Pluripotent Stem Cells
    Theo Stoddard-Bennett, Renee A. Reijo Pera · 2019 · Cells
  51. Lactate controls cancer stemness and plasticity through epigenetic regulation
    Nguyen BT Nguyen, Sira Gevers, Rutger N.U. Kok, Lotte M Burgering, Hannah K. Neikes, Ninouk Akkerman, Max A. Betjes, Marlies C. Ludikhuize, Can M.C. Gulersonmez, Edwin C.A. Stigter et al. · 2025 · Cell Metabolism
  52. REPROGRAMMED CELLS FOR DISEASE MODELING AND REGENERATIVE MEDICINE
    Anne B. C. Cherry, G. Daley · 2013 · Annual Review of Medicine
  53. In Vitro Tissue‐Engineered Skeletal Muscle Models for Studying Muscle Physiology and Disease
    Alastair Khodabukus, Neel K. Prabhu, Jason Wang, Nenad Bursac · 2018 · Advanced Healthcare Materials
  54. mRNA Delivery by a pH‐Responsive DNA Nano‐Hydrogel
    Xin Fu, Tianshu Chen, Yuchen Song, Chang Feng, Huinan Chen, Qianqian Zhang, Guifang Chen, Xiaoli Zhu · 2021 · Small
  55. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity
    Ran Kang, Yan Zhou, Shuang Tan, Guangqian Zhou, Lars Aagaard, Lin Xie, Cody Eric Bünger, Lars Bolund, Yonglun Luo · 2015 · Stem Cell Research & Therapy
  56. Mapping and significance of the mRNA methylome
    Tennille Sibbritt, Hardip R. Patel, Thomas Preiß · 2013 · Wiley Interdisciplinary Reviews - RNA
  57. Myogenic Differentiation of Muscular Dystrophy-Specific Induced Pluripotent Stem Cells for Use in Drug Discovery
    Ramzey Abujarour, Monica H. Bennett, Bahram Bob Valamehr, Tom Tong Lee, Megan Robinson, David Robbins, Thuy My Le, Kevin Lai, Peter Flynn · 2014 · Stem Cells Translational Medicine
  58. Differentiation of induced pluripotent stem cells into functional oligodendrocytes
    M. Czepiel, V. Balasubramaniyan, W. Schaafsma, M. Stančić, H. Mikkers, C. Huisman, E. Boddeke, S. Copray · 2011 · Glia
  59. A simple method for deriving functional MSCs and applied for osteogenesis in 3D scaffolds
    Lijin Zou, Yonglun Luo, Muwan Chen, Gang Wang, Ming Lei Ding, Charlotte Christie Petersen, Ran Kang, Frederik Dagnæs‐Hansen, Yuanlin Zeng, Nonghua Lv et al. · 2013 · Scientific Reports
  60. Self-degradable lipid-like materials based on “hydrolysis accelerated by the intra-particle enrichment of reactant (HyPER)” for messenger RNA delivery
    Tanaka, Hiroki, Takahashi, Tatsunari, Konishi, Manami, Takata, Nae, Gomi, Masaki, Shirane, Daiki, Miyama, Ryo, Hagiwara, Shinya, Yamasaki, Yuki, Sakurai, Yu et al. · 2020 · Advanced Functional Materials
  61. Assessing iPSC reprogramming methods for their suitability in translational medicine
    Mahendra S. Rao, Nasir Malik · 2012 · Journal of Cellular Biochemistry
  62. Integrating Human Pluripotent Stem Cells into Drug Development
    Sandra J. Engle, Dinesh Puppala · 2013 · Cell stem cell
  63. Stepwise Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells Enables Analysis of Glaucomatous Neurodegeneration
    Sarah K. Ohlemacher, Akshayalakshmi Sridhar, Yucheng Xiao, Alexandra Hochstetler, Mansoor Sarfarazi, Theodore Cummins, Jason S. Meyer · 2016 · Stem Cells
  64. hi PSC ‐derived iMSC s: NextGen MSC s as an advanced therapeutically active cell resource for regenerative medicine
    Vikram Sabapathy, Sanjay Kumar · 2016 · Journal of Cellular and Molecular Medicine
  65. Biomedical applications of mRNA nanomedicine
    Xiong, Qingqing, Lee, Gha Young, Ding, Jianxun, Li, Wenliang, Shi, Jinjun · 2018 · Nano Research
  66. Induced Pluripotent Stem Cells and Their Potential for Basic and Clinical Sciences
    Lei Ye, Cory Swingen, Jianyi Jay Zhang · 2013 · Current Cardiology Reviews
  67. Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa
    Umegaki-Arao, Noriko, Pasmooij, Anna M. G., Itoh, Munenari, Cerise, Jane E., Guo, Zongyou, Levy, Brynn, Gostyński, Antoni, Rothman, Lisa R., Jonkman, Marcel F., Christiano, Angela M. · 2014 · Science Translational Medicine
  68. The road to biological pacing
    Michael R. Rosen, Richard B. Robinson, Peter R. Brink, Ira S. Cohen · 2011 · Nature Reviews Cardiology
  69. Delivery systems of current biologicals for the treatment of chronic cutaneous wounds and severe burns
    M. Xue, Ruilong Zhao, Hai-Yan Lin, C. Jackson · 2018 · Advanced Drug Delivery Reviews
  70. Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development
    Richard P. Davis, Cathelijne W. van den Berg, Simona Casini, Stefan R. Braam, Christine L. Mummery · 2011 · Trends in Molecular Medicine
  71. iPS cell technologies and cartilage regeneration
    Noriyuki Tsumaki, Minoru Okada, Akihiro Yamashita · 2014 · Bone
  72. N 1-Methylpseudouridine substitution enhances the performance of synthetic mRNA switches in cells
    Callum Parr, Shunsuke Wada, Kenjiro Kotake, Shigetoshi Kameda, Satoshi Matsuura, Souhei Sakashita, Soyoung Park, Hiroshi Sugiyama, Yi Kuang, Hirohide Saito · 2020 · Nucleic Acids Research
  73. A short adaptive path from DNA to RNA polymerases
    Christopher Cozens, Vitor Bernardes Pinheiro, Alexandra Vaisman, Roger Woodgate, Philipp Holliger · 2012 · Proceedings of the National Academy of Sciences
  74. A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
    Karl‐Josef Kallen, Andreas Theß · 2013 · Therapeutic Advances in Vaccines
  75. Single Cell Transfection through Precise Microinjection with Quantitatively Controlled Injection Volumes
    Yu Ting Chow, Shuxun Chen, Ran Wang, Chichi Liu, Chi‐Wing Kong, Ronald A. Li, Shuk Han Cheng, Dong Bai Sun · 2016 · Scientific Reports
  76. mRNA therapeutics deliver a hopeful message
    Zifu Zhong, Séan Mc Cafferty, Francis Combes, Hanne Huysmans, Joyca De Temmerman, Arlieke Gitsels, Daisy C.G. Vanrompay, João Portela Catani, Niek N. Sanders · 2018 · Nano Today
  77. Messenger RNA delivery of a cartilage-anabolic transcription factor as a disease-modifying strategy for osteoarthritis treatment
    H. Aini, K. Itaka, Ayano Fujisawa, H. Uchida, S. Uchida, S. Fukushima, K. Kataoka, Taku Saito, U. Chung, Shinsuke Ohba · 2016 · Scientific Reports
  78. Autologous Induced Pluripotent Stem Cell–Based Cell Therapies: Promise, Progress, and Challenges
    Marinna Madrid, Cenk Sumen, Suvi Aivio, Nabiha Saklayen · 2021 · Current Protocols
  79. Overcoming the Specific Toxicity of Large Plasmids Electrotransfer in Primary Cells In Vitro
    Lesueur, Léa L, Mir, Lluis M, André, Franck M · 2016 · Molecular Therapy - Nucleic Acids
  80. Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34+ Hematopoietic Stem and Progenitor Cells
    M. Kyle Cromer, Sriram Vaidyanathan, Daniel E. Ryan, Bo Curry, Anne Bergstrom Lucas, Joab Camarena, Milan P. Kaushik, Sarah Hay, Renata M. Martin, Israel Steinfeld et al. · 2018 · Molecular Therapy
  81. Generation of pancreatic β cells for treatment of diabetes: advances and challenges
    H. Shahjalal, Ahmed Abdal Dayem, K. Lim, Tak-il Jeon, Ssang-goo Cho · 2018 · Stem cell research & therapeutics
  82. The WNT receptor FZD7 is required for maintenance of the pluripotent state in human embryonic stem cells
    Antonio Fernandez, Ian J. Huggins, Luca Perna, David A. Brafman, De-Sheng Lu, Shiyin Yao, T. Gaasterland, D. Carson, K. Willert · 2014 · Proceedings of the National Academy of Sciences of the United States of America
  83. Progress in the Reprogramming of Somatic Cells
    Tianhua Ma, Min Xie, Timothy Laurent, Sheng Ding · 2013 · Circulation Research
  84. THERAPY OF ENDOCRINE DISEASE: Treatment of malignant pheochromocytoma and paraganglioma
    Éric Baudin, Mouhammed Amir Habra, Frédèric Deschamps, Gilbert J. Cote, Frédéric Dumont, Maria E. Cabanillas, Julia Arfi, Amandine Berdelou, Bryan Moon, Abir Al Ghuzlan et al. · 2014 · European Journal of Endocrinology
  85. Highly efficient delivery of functional cargoes by the synergistic effect of GAG binding motifs and cell-penetrating peptides
    James E. Dixon, Gizem Osman, Gavin E. Morris, Hareklea Markides, Michael Rotherham, Zahia Bayoussef, Alicia Jennifer El Haj, Chris N. Denning, Kevin M. Shakesheff · 2016 · Proceedings of the National Academy of Sciences
  86. Functional Myogenic Engraftment from Mouse iPS Cells
    Radbod Darabi, Weihong Pan, Darko Bosnakovski, June Baik, Michael Kyba, Rita C. R. Perlingeiro · 2011 · Stem Cell Reviews and Reports
  87. Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases
    Trepotec, Zeljka, Lichtenegger, Eva, Plank, Christian, Aneja, Manish K., Rudolph, Carsten · 2019 · Molecular Therapy
  88. Neural stem cell therapy for stroke: A multimechanistic approach to restoring neurological function
    Emily W. Baker, Holly A. Kinder, Franklin D. West · 2019 · Brain and Behavior
  89. Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity
    Wu, Chuanfeng, Dunbar, Cynthia E. · 2011 · Frontiers of Medicine
  90. Efficient mRNA delivery with graphene oxide-polyethylenimine for generation of footprint-free human induced pluripotent stem cells
    Hye Yeon Choi, Tae‐Jin Lee, Gwang‐Mo Yang, Jaesur Oh, Jihye Won, Jihae Han, Gun‐Jae Jeong, Jongpil Kim, Jin‐Hoi Kim, Byung‐Soo Kim et al. · 2016 · Journal of Controlled Release
  91. Induced Pluripotent Stem Cell-Derived Neural Stem Cell Therapy Enhances Recovery in an Ischemic Stroke Pig Model
    Emily W. Baker, Simon R. Platt, Vivian W. Lau, Harrison E. Grace, Shannon P. Holmes, Liya Wang, Kylee Jo J Duberstein, Elizabeth W. Howerth, Holly A. Kinder, Steven L. Stice et al. · 2017 · Scientific Reports
  92. Ectopic expression of RAD52 and dn53BP1 improves homology-directed repair during CRISPR–Cas9 genome editing
    Bruna S. Paulsen, Pankaj Kumar Mandal, Richard L. Frock, Bariş Boyraz, Rachita Yadav, Srigokul Upadhyayula, Paula Gutierrez‐Martinez, Wataru Ebina, Anders L. Fasth, Tomas L. Kirchhausen et al. · 2017 · Nature Biomedical Engineering
  93. Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles
    Evers, Martijn J.W., Du, Wenjuan, Yang, Qiangbing, Kooijmans, Sander A.A., Vink, Aryan, van Steenbergen, Mies, Vader, Pieter, de Jager, Saskia C.A., Fuchs, Sabine A., Mastrobattista, Enrico et al. · 2022 · Journal of Controlled Release
  94. Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger.
    Devoldere, Joke, Dewitte, Heleen, De Smedt, Stefaan C., Remaut, Katrien · 2016 · Drug Discovery Today
  95. Technological Overview of iPS Induction from Human Adult Somatic Cells
    Émilie Bayart, Odile Cohen‐Haguenauer · 2013 · Current Gene Therapy
  96. 3D In Vitro Model of a Functional Epidermal Permeability Barrier from Human Embryonic Stem Cells and Induced Pluripotent Stem Cells
    Anastasia Petrova, Anna Celli, Laureen Jacquet, Dimitra Dafou, Debra A. Crumrine, Melanie Hupe, Matthew J Arno, Carl Hobbs, Aleksandra Čvoro, Panagiotis Karagiannis et al. · 2014 · Stem Cell Reports
  97. Induced pluripotent stem cells: a new revolution for clinical neurology?
    Virginia B. Mattis, Clive N. Svendsen · 2011 · The Lancet Neurology
  98. Transdifferentiation and reprogramming: Overview of the processes, their similarities and differences
    Artur Cieślar‐Pobuda, Viktoria Knoflach, Mikael V. Ringh, Joachim Stark, Wirginia Likus, Krzysztof Siemianowicz, Saeid Ghavami, Andrzej Hudecki, Jason L. Green, Marek Łoś · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  99. Induced Pluripotency and Epigenetic Reprogramming
    Konrad Hochedlinger, Rudolf Jaenisch · 2015 · Cold Spring Harbor Perspectives in Biology
  100. Microcarrier suspension cultures for high-density expansion and differentiation of human pluripotent stem cells to neural progenitor cells
    Bardy, Jo'an, Chen, Allen K., Lim, Yu Ming, Wu, Selena, Wei, Shunhui, Weiping, Han, Chan, Ken, Reuveny, Shaul, Oh, Steve K.W. · 2013 · Tissue Engineering Part C Methods